M Błaszczyk

2.9k total citations
87 papers, 2.0k citations indexed

About

M Błaszczyk is a scholar working on Pathology and Forensic Medicine, Rheumatology and Dermatology. According to data from OpenAlex, M Błaszczyk has authored 87 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pathology and Forensic Medicine, 28 papers in Rheumatology and 24 papers in Dermatology. Recurrent topics in M Błaszczyk's work include Systemic Sclerosis and Related Diseases (37 papers), Autoimmune Bullous Skin Diseases (23 papers) and Inflammatory Myopathies and Dermatomyositis (16 papers). M Błaszczyk is often cited by papers focused on Systemic Sclerosis and Related Diseases (37 papers), Autoimmune Bullous Skin Diseases (23 papers) and Inflammatory Myopathies and Dermatomyositis (16 papers). M Błaszczyk collaborates with scholars based in Poland, United States and Netherlands. M Błaszczyk's co-authors include Stefania Jabłońska, Tadeusz P. Chorzelski, S Jabłońska, Ernst H. Beutner, T Chorzelski, Hanna Wolska, Maria Trojanowska, Edwin A. Smith, M Jarzabek-Chorzelska and Jaspreet Pannu and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal Of Pathology and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

M Błaszczyk

81 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Błaszczyk Poland 25 1.3k 733 502 336 307 87 2.0k
J. Revuz France 25 1.0k 0.8× 767 1.0× 447 0.9× 527 1.6× 207 0.7× 97 2.1k
Beno Michel United States 20 1.1k 0.8× 652 0.9× 227 0.5× 152 0.5× 182 0.6× 50 1.6k
Norihito Yazawa Japan 25 814 0.6× 440 0.6× 265 0.5× 372 1.1× 585 1.9× 55 1.6k
Kenichi Yamane Japan 28 1.0k 0.8× 233 0.3× 460 0.9× 272 0.8× 311 1.0× 69 2.4k
Yutaka Okano Japan 22 1.3k 1.0× 618 0.8× 348 0.7× 928 2.8× 433 1.4× 66 2.0k
Filemon K. Tan United States 37 1.9k 1.4× 842 1.1× 548 1.1× 597 1.8× 907 3.0× 65 3.2k
Takamitsu Makino Japan 23 789 0.6× 210 0.3× 433 0.9× 238 0.7× 438 1.4× 83 1.9k
Paolo Fraticelli Italy 16 948 0.7× 313 0.4× 250 0.5× 266 0.8× 866 2.8× 38 2.1k
Raphaël Lemaire United States 22 716 0.5× 269 0.4× 229 0.5× 181 0.5× 393 1.3× 31 1.7k
Matthias S. Gruschwitz Germany 16 728 0.5× 231 0.3× 320 0.6× 148 0.4× 496 1.6× 28 1.4k

Countries citing papers authored by M Błaszczyk

Since Specialization
Citations

This map shows the geographic impact of M Błaszczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Błaszczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Błaszczyk more than expected).

Fields of papers citing papers by M Błaszczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Błaszczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Błaszczyk. The network helps show where M Błaszczyk may publish in the future.

Co-authorship network of co-authors of M Błaszczyk

This figure shows the co-authorship network connecting the top 25 collaborators of M Błaszczyk. A scholar is included among the top collaborators of M Błaszczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Błaszczyk. M Błaszczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palko-Łabuz, Anna, Olga Wesołowska, M Błaszczyk, et al.. (2024). Methoxychalcones as potential anticancer agents for colon cancer: Is membrane perturbing potency relevant?. Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(4). 130581–130581.
2.
Wesołowska, Olga, Anna Duda-Madej, M Błaszczyk, et al.. (2024). Interaction of selected alkoxy naringenin oximes with model and bacterial membranes. Biomedicine & Pharmacotherapy. 174. 116581–116581.
3.
Błaszczyk, M. (2012). Cutaneous sarcoidosis: clinical presentation and diagnostic difficulties. 99(3). 185–194. 1 indexed citations
4.
Dwilewicz‐Trojaczek, Jadwiga, et al.. (2011). Dwa przypadki scleromyxedema. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Pannu, Jaspreet, Yoshihide Asano, Sashidhar Nakerakanti, et al.. (2008). Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Arthritis & Rheumatism. 58(8). 2528–2537. 70 indexed citations
6.
Kowaléwski, Cezary, et al.. (2004). Alterations of Basement Membrane Zone in Bullous and Non-Bullous Variants of Extragenital Lichen Sclerosus. American Journal of Dermatopathology. 26(2). 96–101. 11 indexed citations
7.
Jabłońska, Stefania & M Błaszczyk. (2002). Scleroderma and sclerotic skin conditions: unapproved treatments. Clinics in Dermatology. 20(6). 634–637. 7 indexed citations
8.
Błaszczyk, M, et al.. (2000). Parakeratosis variegata: A Possible Role of Environmental Hazards?. Dermatology. 201(1). 54–57. 4 indexed citations
9.
Jabłońska, Stefania & M Błaszczyk. (2000). Scleroderma‐like Indurations Involving Fascias: An Abortive Form of Congenital Fascial Dystrophy (Stiff Skin Syndrome). Pediatric Dermatology. 17(2). 105–110. 18 indexed citations
10.
Hausmanowa-Pétrusewicz, I, M Błaszczyk, & S Jabłońska. (1995). Coexistence of scleromyositis associated with PM-SCL antibody and myasthenia. Neuromuscular Disorders. 5(2). 145–147. 10 indexed citations
11.
Beutner, Ernst H., M Błaszczyk, S. Jabłońska, Tadeusz P. Chorzelski, & Vijay Kumar. (1992). Preliminary dermatologic criteria to classify cases of cutaneous lupus erythematosus. Journal of Investigative Dermatology. 98(4). 599. 7 indexed citations
12.
Błaszczyk, M, Stephania Jabłońska, Tadeusz P. Chorzelski, et al.. (1992). Clinical relevance of immunologic findings in cutaneous lupus erythematosus. Clinics in Dermatology. 10(4). 399–IN2. 6 indexed citations
13.
Beutner, Ernst H., M Błaszczyk, Stefania Jabłońska, et al.. (1991). Studies on Criteria of the European Academy of Dermatology and Venerology for the Classification of Cutaneous Lupus Erythematosus. International Journal of Dermatology. 30(6). 411–417. 43 indexed citations
14.
Błaszczyk, M, et al.. (1991). Immunologic Markers of Systemic Scleroderma in Children. Pediatric Dermatology. 8(1). 13–20. 9 indexed citations
15.
Majewski, Sławomir, et al.. (1990). Cytotoxic effects of sera from patients with systemic scleroderma: Comparison of three different in vitro methods. Rheumatology International. 10(2). 65–70. 3 indexed citations
16.
17.
Wolska, Hanna, M Błaszczyk, & Stefania Jabłońska. (1989). Phototests in Patients with Various Forms of Lupus Erythematosus. International Journal of Dermatology. 28(2). 98–103. 57 indexed citations
18.
Majewski, Sławomir, et al.. (1987). Serum levels of type III collagen aminopropeptide in patients with systemic scleroderma. Archives of Dermatological Research. 279(7). 484–486. 15 indexed citations
19.
Chorzelski, T, et al.. (1967). [Immunofluorescent studies in the diagnosis of lupus erythematosus].. PubMed. 54(5). 541–7. 1 indexed citations
20.
Chorzelski, T, Stefania Jabłońska, & M Błaszczyk. (1966). [Immunopathological studies on the subcorneal pustular dermatosis of Sneddon-Wilkinson].. PubMed. 107(5). 809–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Revuz Breakdown of academic impact, for papers by Beno Michel Breakdown of academic impact, for papers by Norihito Yazawa Breakdown of academic impact, for papers by Kenichi Yamane Breakdown of academic impact, for papers by Yutaka Okano Breakdown of academic impact, for papers by Filemon K. Tan Breakdown of academic impact, for papers by Takamitsu Makino Breakdown of academic impact, for papers by Paolo Fraticelli Breakdown of academic impact, for papers by Raphaël Lemaire Breakdown of academic impact, for papers by Matthias S. Gruschwitz
Rankless by CCL
2026